share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Arcutis Biotherapeutics | 144:擬議出售證券
美股SEC公告 ·  2024/11/05 05:45

Moomoo AI 已提取核心訊息

Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,015 shares of common stock on 11/04/2024, as per the latest filing. The shares, acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics, have an aggregate market value of $43,551. This transaction follows a period where no other sales were reported in the past three months.
Arcutis Biotherapeutics, Inc. officer Matsuda Masaru is set to sell 5,015 shares of common stock on 11/04/2024, as per the latest filing. The shares, acquired on 11/01/2024 through a restricted stock vest from Arcutis Biotherapeutics, have an aggregate market value of $43,551. This transaction follows a period where no other sales were reported in the past three months.
arcutis biotherapeutics公司官員松田勝準備在2024年11月4日賣出5,015股普通股,根據最新提交的文件。這些股票是在2024年11月1日通過arcutis biotherapeutics的受限股票分配獲得的,市值合計43,551美元。此交易發生在過去三個月中未報告其他銷售的時期之後。
arcutis biotherapeutics公司官員松田勝準備在2024年11月4日賣出5,015股普通股,根據最新提交的文件。這些股票是在2024年11月1日通過arcutis biotherapeutics的受限股票分配獲得的,市值合計43,551美元。此交易發生在過去三個月中未報告其他銷售的時期之後。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息